The Delaware Court of Chancery approved a class settlement of claims against Aytu BioPharma Inc. and directors relating to affiliated transactions and trading.

Lead plaintiff ATG Fund II LLC has filed for final approval of a $7 million settlement of claims arising from the liquidation of VPC Impact Acquisition Holdings II, a special purpose acquisition company.

Aaron Morris submitted a written comment to the Securities & Exchange Commission in connection with an ill-conceived proposal to exempt closed-end funds from the annual shareholder meeting requirement.

Morris Kandinov LLP, on behalf of the lead plaintiff, filed motions for final approval and for reimbursement of fees and expenses in connection with SPAC settlement.

Lead plaintiff Funicular Funds, LP and lead counsel Morris Kandinov filed a motion for preliminary approval of a $13 million settlement of claims arising from the liquidation of Pioneer Merger […]

FAST SPAC’s agreement to pay $12.5 million to investors in connection with its broken merger was approved by the Delaware Court of Chancery.

The U.S. District Court certified a class of Pioneer Merger Corp. stockholders in a dispute over the distribution of a termination fee paid to the SPAC following a broken transaction.

Morris Kandinov LLP is representing Camac Fund, LP in an action against the board of directors of Forte Biosciences, Inc. and other defendants who attempted to fix the vote in advance of the company’s annual meeting.

U.S. District Court denies defendants’ motion to dismiss in dispute over $32.5 million termination fee payment.

The Delaware Chancery Court rejected an interlocutory appeal of the Court’s prior ruling denying defendants’ motion to dismiss, permitting discovery to proceed in the case.